<DOC>
	<DOCNO>NCT00460187</DOCNO>
	<brief_summary>Multicenter , prospective , pivotal study design demonstrate safety efficacy Lumen Biomedical , Inc. FiberNet® Embolic Protection System adjunctive device carotid artery percutaneous intervention high surgical risk patient .</brief_summary>
	<brief_title>EPIC US Pivotal Study</brief_title>
	<detailed_description />
	<criteria>One high surgical risk criterion . Symptomatic atherosclerotic stenosis ≥ 50 % asymptomatic atherosclerotic stenosis ≥ 70 % carotid artery NASCET Criteria . Prior stenting ipsilateral carotid . Planned treatment contralateral carotid within 30 day . Experienced myocardial infarction within last 14 day . Undergone angioplasty PTCA/PTA procedure within past 48 hour . Undergone cardiac surgery within past 60 day . Suffered stroke within past 14 day . Suffered transient ischemic neurological attack ( TIA ) amaurosis fugax within past 48 hour . Abnormal baseline blood count ; platelet &lt; 50,000 &gt; 700,000/mm3 WBC count &lt; 3 x103/uL . Intracranial stenosis exceed severity extracranial stenosis . Total occlusion target vessel . Lesion within 2cm ostium common carotid artery . A stenosis know unsuitable stenting Serial lesion require one stent cover entire lesion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>carotid artery , distal protection device , carotid stenting</keyword>
</DOC>